Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

10 actions you can take this Dementia Action Week

Dementia Action Week is a national initiative led by Alzheimer’s Society to encourage people to take action to improve the lives of people living with dementia.

What is cognition?

The words 'cognition' and 'cognitive' crop up a lot in the field of dementia – but what do they really mean?

Amyloid and tau: the proteins involved in dementia

There are two main proteins thought to interfere with the communication between brain cells in certain dementias – tau and amyloid.

Diet and dementia

We've looked at the evidence surrounding the reported benefits of different foods for preventing and delaying dementia.

Dementia's relationship with Parkinson's

There are two types of dementia closely related to Parkinson's disease: dementia with Lewy bodies and Parkinson's dementia.

The time is right to focus on pre-clinical dementia

Writing in The Conversation, DPUK's clinician-researcher Dr Ivan Koychev says now is the time to focus on tackling dementia before symptoms start to appear.

Leaving the lab but not the field: research-related careers in dementia

To mark Dementia Researcher’s careers festival (part of National Careers Week in the UK), we spoke to four people who moved from a research career into roles including science communication and project management.

New podcast: Increasing diversity in dementia research

In our latest podcast, we speak to Feyi Raimi-Abraham, founder of the Black Dementia Company.

Frontotemporal dementia: a common form of young-onset dementia

Frontotemporal dementia (FTD) is the second most common form of young-onset dementia, with several different subtypes involving changes in behaviour, personality and language skills.

DPUK Data Portal showcased in new podcast for early-career researchers

In the latest episode of the Dementia Researcher podcast, Dr Sarah Bauermeister and Dr Danielle Newby explain how researchers can use the DPUK Data Portal to generate valuable new insights into dementia.

Sundowning: the condition with symptoms that appear at sunset

Usually seen in people with mid-to-late-stage dementia, sundown syndrome is the appearance of regular behavioural changes such as agitation and confusion around sunset.

Could oestrogen explain why women are more at risk of dementia?

Women are at greater risk of developing dementia than men, and the hormone oestrogen could be a reason why.

Posterior cortical atrophy: a dementia that affects the vision

Posterior cortical atrophy (PCA) is a type of young-onset dementia affecting vision that is caused not by problems with the eyes, but by damage to the back of the brain.

What's it like to take part in a DPUK datathon?

We spoke to Dr Donncha Mullin, a participant in the virtual DPUK datathon held in November 2020, about what it's like to take part in one of these events.

State-of-the-art brain scanners offer ‘incredible opportunities’ for dementia research

At a virtual event hosted by SONA (the Society of Neuroscientists of Africa), DPUK’s Imaging Network lead, Professor Franklin Aigbirhio, explained how PET-MR scanners are enhancing dementia research.

Wernicke-Korsakoff Syndrome: a treatable memory disorder

We most often associate the symptoms of dementia with high-profile conditions such as Alzheimer’s disease or Parkinson’s. But dementia comes in many forms, and has many causes.

Vascular dementia: investigating cognitive impairment with 2,000 stroke survivors

Stroke and vascular dementia are intrinsically related, with both being a risk factor for the other. Researchers at the University of Edinburgh led by Professor Joanna Wardlaw are studying stroke patients to learn more about the cognitive impairment that often follows a stroke, thanks to a grant from DPUK that allowed them to get started.

Symptomatic drugs for cognitive impairment in dementia: what to expect?

Dr Ivan Koychev, of DPUK and Oxford University's Department of Psychiatry, writes about new research into the effectiveness of drugs to treat the symptoms of dementia.

New podcast: DPUK's Professor John Gallacher on the future of dementia research

We caught up with Professor John Gallacher, Director of Dementias Platform UK and Professor of Cognitive Health at Oxford University, to get his thoughts on the current state of play in dementia research – and what the future might hold.

Coronavirus care: supporting loved ones with dementia

Supporting a family member through dementia is not easy, and the extra challenges introduced by the coronavirus lockdown can make matters even more challenging. Guest blogger Ruby Clarkson summarises the best advice and the help that's available.

Load More